Literature DB >> 14739023

In vitro activity of quinolines against Plasmodium falciparum in Gabon.

M Ramharter1, W H Wernsdorfer, P G Kremsner.   

Abstract

The assessment of drug sensitivity of Plasmodium falciparum to antimalarial drugs is of vital interest for malaria endemic regions. We conducted a follow-up study to monitor the in vitro activity of the most commonly used quinolines against fresh P. falciparum isolates in Lambaréné, Gabon by measuring schizont maturation inhibition in 2002. Mean 50% effective concentration levels for chloroquine, quinine, and mefloquine were 5.5micromol/l blood, 286nmol/l blood medium mixture (BMM), and 1.1micromol/l blood, respectively. All isolates (n=40) were found to be highly resistant to chloroquine. One isolate was resistant to mefloquine and five isolates were presenting borderline-resistance. All isolates were inhibited by quinine concentrations below the threshold of resistance (n=43). Besides the observation of an increasing number of borderline resistant isolates to mefloquine, an extremly high parasite resistance to chloroquine-still officially the first line antimalarial in Gabon-seems to be of particular concern.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14739023     DOI: 10.1016/j.actatropica.2003.11.001

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  21 in total

1.  Efficacy and safety of a new pediatric artesunate-mefloquine drug formulation for the treatment of uncomplicated falciparum malaria in Gabon.

Authors:  Marielle K Bouyou-Akotet; Michael Ramharter; Edgard Brice Ngoungou; Modeste Mabika Mamfoumbi; Mireille Pemba Mihindou; Michel A Missinou; Florian Kurth; Sabine Bélard; Selidji T Agnandji; Saadou Issifou; János L Heidecker; Sonja Trapp; Peter G Kremsner; Maryvonne Kombila
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

2.  Neonatal and maternal immunological responses to conserved epitopes within the DBL-gamma3 chondroitin sulfate A-binding domain of Plasmodium falciparum erythrocyte membrane protein 1.

Authors:  Kim Brustoski; Martin Kramer; Ulrike Möller; Peter G Kremsner; Adrian J F Luty
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  In vitro activity of antifungal drugs against Plasmodium falciparum field isolates.

Authors:  Peter Pongratz; Florian Kurth; Ghyslain Mombo Ngoma; Arti Basra; Michael Ramharter
Journal:  Wien Klin Wochenschr       Date:  2011-07-07       Impact factor: 1.704

4.  Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections.

Authors:  Christian Supan; Ghyslain Mombo-Ngoma; Matthias P Dal-Bianco; Carmen L Ospina Salazar; Saadou Issifou; Florent Mazuir; Aziz Filali-Ansary; Christophe Biot; Daniel Ter-Minassian; Michael Ramharter; Peter G Kremsner; Bertrand Lell
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

5.  Antimalarial activity of a synthetic endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum isolates from Gabon.

Authors:  Andrea Kreidenweiss; Benjamin Mordmüller; Sanjeev Krishna; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

6.  Population Pharmacokinetics of Mefloquine Intermittent Preventive Treatment for Malaria in Pregnancy in Gabon.

Authors:  Michael Ramharter; Matthias Schwab; Clara Menendez; Reinhold Kerb; Thorsten Lehr; Ghyslain Mombo-Ngoma; Rella Zoleko Manego; Daisy Akerey-Diop; Arti Basra; Jean-Rodolphe Mackanga; Heike Würbel; Jan-Georg Wojtyniak; Raquel Gonzalez; Ute Hofmann; Mirjam Geditz; Pierre-Blaise Matsiegui; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

7.  The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5-HT3 receptors.

Authors:  A J Thompson; M Lochner; S C R Lummis
Journal:  Br J Pharmacol       Date:  2007-05-14       Impact factor: 8.739

8.  Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin.

Authors:  Mesküre Capan; Ghyslain Mombo-Ngoma; Athanasios Makristathis; Michael Ramharter
Journal:  Malar J       Date:  2010-10-29       Impact factor: 2.979

9.  Antimalarial drugs inhibit human 5-HT(3) and GABA(A) but not GABA(C) receptors.

Authors:  A J Thompson; S C R Lummis
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

10.  Automated red blood cell exchange as an adjunctive treatment for severe Plasmodium falciparum malaria at the Vienna General Hospital in Austria: a retrospective cohort study.

Authors:  Lorenz Auer-Hackenberg; Thomas Staudinger; Andja Bojic; Gottfried Locker; Gerda C Leitner; Wolfgang Graninger; Stefan Winkler; Michael Ramharter; Nina Worel
Journal:  Malar J       Date:  2012-05-07       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.